Target function, not a species
The objective is a measured host-facing signal such as butyrate, bile-acid balance, indole signaling, barrier state, or inflammatory tone — not simply making a named organism more abundant.
← Discovery
Discovery story
Microbiome ecosystem programming and microbial indirection.
Ecosystem-level programming of the microbiome, with indirection through microbial pathways.
Microbiome-mediated indirection
Program the ecosystem, not only the final receptor ligand.
A peptide can hit a human receptor directly. This layer adds another level of indirection: steer helper organisms, cross-feeding intermediates, and microbial functions so the host-facing metabolite or signal changes in a measurable way.
claim boundary
Rank-only ecosystem-control planning layer. It does not claim colonization, metabolite flux, host response, safety, efficacy, clinical utility, or regulatory readiness without measured microbiome, metabolomics, tolerance, and host-outcome data.
risk ladder
- 1diet pattern / timing / substrate context
- 2prebiotic or polyphenol ecological steering
- 3postbiotic or defined bacterial component
- 4non-engineered live strain or defined consortium
- 5engineered live biotherapeutic
- 6phage or CRISPR microbiome editing
Use helper chains deliberately
A substrate may feed a helper organism, which produces acetate, lactate, mucin sugars, or another intermediate that enables the real target organism or guild.
Measure flux and host response
Every pathway emits required measurements: stool taxa/function, targeted metabolomics, symptoms/tolerance, CGM/labs, inflammatory markers, and body-state endpoints.
Escalate modality risk slowly
Start with diet/prebiotic and postbiotic hypotheses. Live strains, engineered LBPs, phage, and CRISPR microbiome editing stay behind biosafety and regulatory review.
butyrate flux → metabolic resilience · barrier · inflammatory load
rank-onlyAkkermansia as helper, not final target
Akkermansia can be modeled as an upstream mucus-layer actuator that releases acetate and mucin-derived substrates, enabling acetate-consuming butyrate producers such as Anaerostipes-like guilds.
substrate
mucus-layer / polyphenol context
creates upstream ecological conditions
helper
Akkermansia muciniphila
mucin-associated helper organism
signal
acetate + mucin-derived oligosaccharides
cross-feed intermediates
target
Anaerostipes / butyrate guild
secondary consumer and final producer
host
butyrate → epithelial / immune-metabolic state
host-facing output to validate
measurements needed
stool taxa/functionSCFA panelGI toleranceCGM/labshsCRP/CBC
Akkermansia abundance alone is not the endpoint; butyrate flux and host-state response are.
butyrate flux → barrier and inflammatory tone
rank-onlyBifidobacterium helper chain
Bifidobacterium-like primary degraders can produce acetate/lactate intermediates that feed lactate- and acetate-consuming butyrate producers, provided the consuming guild is present.
substrate
inulin / oligosaccharides
feeds primary degrader
helper
Bifidobacterium spp.
produces acetate and lactate
signal
acetate + lactate
intermediate pool
target
Eubacterium hallii / Anaerostipes
lactate/acetate consumers
host
butyrate → barrier / immune readout
measured endpoint
measurements needed
baseline butyrate guildSCFA panelbloating/tolerancestool functioninflammatory markers
Do not increase lactate production without verifying lactate consumption capacity and tolerance.
secondary bile-acid profile → lipid · glucose · appetite signaling
rank-onlyMeasurement-first bile-acid guild
Bile-acid transformation is guild- and species-dependent. It should be mapped before steering because the same class can carry beneficial or harmful signals depending on species and concentration.
substrate
primary bile-acid pool
baseline context
helper
Bacteroides / Clostridia context
transformation environment
target
bile-acid converter guild
enzymatic transformation
signal
secondary bile acids
TGR5 / FXR-context signal
host
liver / enteroendocrine / metabolic state
directional response
measurements needed
primary/secondary bile acidslipidsglucose/insulinmedicationsGI tolerance
Directionality is not assumed; species-resolved bile-acid data comes before intervention.
DiscoveryLab backend: experiments/microbiome-ecosystem-hypothesis-graph-v0/ emits scorecards that the Agentic Evidence Graph ingests as microbial_crossfeeding_pathway and ecosystem_control_plan claims.
More on discovery
Related on this track
Problem
Why brute-force peptide search fails.
Modality fit
Causal-node and receptor-gate routing.
Hair-loss program
Local follicle-regeneration workbench.
CNS pack
Small-molecule CNS translational evidence layer.
MOTS-c candidate
Evidence-backed seed framing.
Natural seeds
Parent peptide library and guardrails.
Search space
Eight-stage reduction strategy.
← Back to Discovery index
All sections on the discovery track.